Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72847 record(s)

Req # A-2023-000138

The most current Health Canada approved Risk Management Plan on file for Eylea.

Organization: Health Canada

408 page(s)
May 2024

Req # A-2023-000431

Correspondence to and from the minister of Mental Health and Addictions concerning possible changes to the guidance on alcohol consumption in the time frame: July 1, 2022 to June 26th, 2023.

Organization: Health Canada

531 page(s)
May 2024

Req # A-2023-000981

The Health Canada indication for Medical Device License (MDL) 69955, specifically, the Contour branded indication, Manufacturer PROLLENIUM MEDICAL TECHNOLOGIES INC.

Organization: Health Canada

57 page(s)
May 2024

Req # A-2023-001003

The Certified Product Information Document (CPID) submitted for the Treosulfan Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

23 page(s)
May 2024

Req # A-2023-001005

The Abbreviated New Drug Submission (ANDS) cover letter of the company who submitted the Rupatadine ANDS.

Organization: Health Canada

2 page(s)
May 2024

Req # A-2023-001006

The Certified Product Information Document (CPID) submitted for the Rupatadine Abbreviated New Drug Submission (ANDS).

Organization: Health Canada

25 page(s)
May 2024

Req # A-2023-001007

The Abbreviated New Drug Submission (ANDS) cover letter of the company who submitted the Treosulfan ANDS.

Organization: Health Canada

4 page(s)
May 2024

Req # A-2023-001120

With respect to the Pfizer report entitled, Periodic Safety Update Report, provide: the date it was received; the date when the review was completed and by whom including expertise/specialty; findings including: identified risks of the vaccine;…

Organization: Health Canada

609 page(s)
May 2024

Req # A-2023-001172

All decisions, including “No Objection” letters or equivalent, with respect to exemptions of “decocainized coca leaf extract” or “decocainized coca leaf extract” or “cocaine-free coca leaf extract” from the Controlled Drugs and Substances Act and…

Organization: Health Canada

0 page(s)
May 2024

Req # A-2023-001194

All test results relating to the contamination of cantaloupe products, including Malichita or Rudy brand cantaloupes. All emails between Health Canada representatives/employees relating to the contamination of cantaloupe products, including…

Organization: Health Canada

378 page(s)
May 2024
Date modified: